U.S. markets closed
  • S&P Futures

    3,740.75
    -24.75 (-0.66%)
     
  • Dow Futures

    30,705.00
    -173.00 (-0.56%)
     
  • Nasdaq Futures

    12,335.50
    -119.50 (-0.96%)
     
  • Russell 2000 Futures

    2,117.90
    -26.60 (-1.24%)
     
  • Crude Oil

    63.89
    +0.06 (+0.09%)
     
  • Gold

    1,689.30
    -11.40 (-0.67%)
     
  • Silver

    25.18
    -0.28 (-1.08%)
     
  • EUR/USD

    1.1956
    -0.0023 (-0.19%)
     
  • 10-Yr Bond

    1.5500
    +0.0800 (+5.44%)
     
  • Vix

    28.57
    +1.90 (+7.12%)
     
  • GBP/USD

    1.3873
    -0.0021 (-0.15%)
     
  • USD/JPY

    107.9130
    -0.0630 (-0.06%)
     
  • BTC-USD

    46,648.80
    -4,276.48 (-8.40%)
     
  • CMC Crypto 200

    931.11
    -56.10 (-5.68%)
     
  • FTSE 100

    6,650.88
    -24.59 (-0.37%)
     
  • Nikkei 225

    28,446.83
    -483.28 (-1.67%)
     

AstraZeneca expects U.S. COVID-19 vaccine authorization in April

  • Oops!
    Something went wrong.
    Please try again later.

Feb 23 (Reuters) - AstraZeneca Plc expects its COVID-19 vaccine could receive U.S. Emergency Use Authorization at the beginning of April and could immediately deliver 30 million doses of the shot there, a top executive said at a hearing in the U.S. House of Representatives on Tuesday.

Ruud Dobber, executive vice president at AstraZeneca, said that the drugmaker expects to be able to deliver 50 million doses of the vaccine by the end of April. (Reporting by Michael Erman)